Healthcare / Medical Care FacilitiesTokyo
$815.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 10%
FCF escenarios
weak_data · normalized FCF $-710.8M · quality 22.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.2B
P/E
15.1x
↓EV/EBITDA
10.1x
↓ROE
5.8%
↑Gross Margin
13.0%
↓Debt/Equity
2.53
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.0%
FCF CAGR
—
FCF margin
-14.5%
FCF / Net income
-8.67x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.89B · net income $82.0M · FCF $-710.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.89B | $4.89B | $4.71B | $4.25B | $4.10B |
| Net Income | $82.0M | $82.0M | $125.4M | $126.7M | $157.5M |
| EBITDA | $359.3M | $359.3M | $344.6M | $300.8M | $334.7M |
| EPS | — | — | 82.86 | 82.87 | 103.10 |
| Gross Margin | 13.0% | 13.0% | 14.0% | 15.2% | 16.7% |
| Operating Margin | 0.8% | 0.8% | 3.2% | 2.6% | 4.7% |
| Net Margin | 1.7% | 1.7% | 2.7% | 3.0% | 3.8% |
| Balance Sheet | |||||
| Debt/Equity | 2.53 | 2.53 | 2.11 | 1.90 | 1.24 |
| Current Ratio | 1.16 | 1.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-710.8M | $-710.8M | $-797.4M | $-597.4M | $303.0M |
| Returns | |||||
| ROE | 5.8% | 5.8% | 9.4% | 10.6% | 14.5% |
| Valuation | |||||
| P/E | 15.09 | 15.09 | 11.10 | 14.83 | 20.05 |
| EV/EBITDA | 10.11 | 10.11 | 8.90 | 9.16 | 10.19 |
| P/B | 0.88 | 0.88 | 1.05 | 1.58 | 2.91 |
| Growth & Yield | |||||
| Revenue Growth | 3.8% | 3.8% | 10.7% | 3.7% | — |
| EPS Growth | — | — | -0.0% | -19.6% | — |
| Dividend Yield | 1.2% | 1.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+10.1%
Start / end P/E
n/dx → n/dx
EPS bridge
82.86 → n/d
Residual
+8.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.